FDA Accelerates Review of Keytruda Combo as Initial Therapy for Inoperable Advanced or Metastatic Malignant Pleural Mesothelioma.
FDA Grants Priority Review to Keytruda Combination as a First-Line Treatment for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma In a significant development for patients with unresectable advanced or metastatic malignant pleural mesothelioma, the U.S. Food and Drug Administration (FDA) has granted Priority Review status to a new treatment combination involving Keytruda (pembrolizumab). This decision […]
AI Boosts Biopharma Sustainability, but at What Environmental Cost?
Artificial intelligence (AI) is emerging as a powerful tool for biopharma companies seeking to enhance their sustainability efforts. By leveraging AI-driven insights, these organizations can potentially optimize resource utilization, reduce waste, and minimize their environmental footprint. However, the environmental cost of AI itself raises questions about the net impact of this technology on sustainability. AI […]
AI for Greener Biopharma: Balancing Sustainability and Environmental Cost
Artificial intelligence (AI) is emerging as a powerful tool for biopharma companies seeking to enhance their sustainability efforts. By leveraging AI-driven insights, these organizations can potentially optimize resource utilization, reduce waste, and minimize their environmental footprint. However, the question remains: do the sustainability benefits of AI outweigh its own environmental cost? AI algorithms require vast […]